[Anti-HL-A antibodies not fixing complément (blocking)].
D000293:Adolescent; D000906:Antibodies / Q000032:analysis*; D001792:Blood Platelets / Q000276:immunology; D002648:Child; D003168:Complement Fixation Tests; D003169:Complement Inactivator Proteins; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006649:Histocompatibility Antigens; D006801:Humans; D007114:Immunization; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007167:Immunotherapy / Q000009:adverse effects; D007938:Leukemia / Q000628:therapy; D008233:Lymphotoxin-alpha; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D065227:Transfusion Reaction
D000906:Antibodies; D003169:Complement Inactivator Proteins; D006649:Histocompatibility Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008233:Lymphotoxin-alpha
Anticorps anti-HL-A ne fixant pas le complément (bloquants)